Ko Hatanaka

584 total citations
20 papers, 487 citations indexed

About

Ko Hatanaka is a scholar working on Pharmacology, Biochemistry and Organic Chemistry. According to data from OpenAlex, Ko Hatanaka has authored 20 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 4 papers in Biochemistry and 3 papers in Organic Chemistry. Recurrent topics in Ko Hatanaka's work include Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Pain Management and Opioid Use (3 papers). Ko Hatanaka is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Pain Management and Opioid Use (3 papers). Ko Hatanaka collaborates with scholars based in Japan and Germany. Ko Hatanaka's co-authors include Michiko Kawamura, Yoshiteru Harada, Makoto Katori, Keiko Ogino, Maki Saito, Michiko Ogino, Masataka Majima, Takashi Ohno, Shozo Yamamoto and Masamichí Okada and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Journal of Leukocyte Biology.

In The Last Decade

Ko Hatanaka

20 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ko Hatanaka Japan 13 188 122 94 67 60 20 487
Annette Tomlinson United Kingdom 12 292 1.6× 199 1.6× 108 1.1× 224 3.3× 80 1.3× 15 793
Julie Y. Crider United States 21 285 1.5× 398 3.3× 173 1.8× 154 2.3× 79 1.3× 36 1.1k
Paul DaSilva‐Jardine United States 12 182 1.0× 270 2.2× 94 1.0× 61 0.9× 171 2.9× 16 659
Seu‐Mei Wang Taiwan 17 86 0.5× 384 3.1× 40 0.4× 58 0.9× 26 0.4× 37 687
Kenneth E. Eakins United States 15 282 1.5× 191 1.6× 78 0.8× 135 2.0× 43 0.7× 27 832
Cheng Yun-lin China 10 57 0.3× 226 1.9× 64 0.7× 37 0.6× 22 0.4× 18 426
N A Plummer United Kingdom 12 121 0.6× 96 0.8× 62 0.7× 48 0.7× 53 0.9× 24 540
Akira Wakizaka Japan 12 64 0.3× 222 1.8× 35 0.4× 28 0.4× 48 0.8× 33 511
Susumu Otomo Japan 14 66 0.4× 356 2.9× 207 2.2× 88 1.3× 20 0.3× 73 657
Rebecca Salmonsen United States 13 125 0.7× 284 2.3× 117 1.2× 37 0.6× 18 0.3× 24 587

Countries citing papers authored by Ko Hatanaka

Since Specialization
Citations

This map shows the geographic impact of Ko Hatanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Hatanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Hatanaka more than expected).

Fields of papers citing papers by Ko Hatanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ko Hatanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Hatanaka. The network helps show where Ko Hatanaka may publish in the future.

Co-authorship network of co-authors of Ko Hatanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Ko Hatanaka. A scholar is included among the top collaborators of Ko Hatanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Hatanaka. Ko Hatanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amano, Hideki, Yoshio Matsui, Ko Hatanaka, Kanako Hosono, & Yoshiya Ito. (2021). VEGFR1-tyrosine kinase signaling in pulmonary fibrosis. Inflammation and Regeneration. 41(1). 16–16. 27 indexed citations
2.
Kawamura, Michiko, et al.. (2009). Contribution of the Prostaglandin E2/E-Prostanoid 2 Receptor Signaling Pathway in Abscess Formation in Rat Zymosan-Induced Pleurisy. Journal of Pharmacology and Experimental Therapeutics. 331(3). 860–870. 4 indexed citations
3.
Nakano, Masashi, Misako Matsumoto, Michiko Kawamura, et al.. (2006). Interaction between cyclooxygenase (COX)-1- and COX-2-products modulates COX-2 expression in the late phase of acute inflammation. European Journal of Pharmacology. 559(2-3). 210–218. 14 indexed citations
4.
Yamaguchi, Sayuri, Michiko Kawamura, Ko Hatanaka, et al.. (2005). Local and systemic expression of inducible nitric oxide synthase in comparison with that of cyclooxygenase-2 in rat carrageenin-induced pleurisy. Nitric Oxide. 12(2). 80–88. 12 indexed citations
5.
Nagai, Kiyohito, et al.. (2003). Concurrent evolution and resolution in an acute inflammatory model of rat carrageenin-induced pleurisy. Journal of Leukocyte Biology. 73(4). 456–463. 27 indexed citations
6.
Hatanaka, Ko, et al.. (2001). FR167653, a Cytokine Synthesis Inhibitor, Exhibits Anti-Inflammatory Effects Early in Rat Carrageenin-Induced Pleurisy but No Effect Later. Journal of Pharmacology and Experimental Therapeutics. 299(2). 519–527. 6 indexed citations
7.
Kawamura, Michiko, Ko Hatanaka, Maki Saito, et al.. (2000). Are the anti-inflammatory effects of dexamethasone responsible for inhibition of the induction of enzymes involved in prostanoid formation in rat carrageenin-induced pleurisy?. European Journal of Pharmacology. 400(1). 127–135. 37 indexed citations
8.
Ogino, Keiko, Ko Hatanaka, Michiko Kawamura, Takashi Ohno, & Yoshiteru Harada. (2000). Meloxicam Inhibits Prostaglandin E<sub>2</sub> Generation via Cyclooxygenase 2 in the Inflammatory Site but Not That via Cyclooxygenase 1 in the Stomach. Pharmacology. 61(4). 244–250. 10 indexed citations
9.
Harada, Yoshiteru, Michiko Kawamura, Ko Hatanaka, et al.. (1998). Differing Profiles of Prostaglandin Formation Inhibition Between Selective Prostaglandin H Synthase-2 Inhibitors and Conventional NSAIDs in Inflammatory and Non-Inflammatory Sites of the Rat. Prostaglandins & Other Lipid Mediators. 55(5-6). 345–358. 16 indexed citations
10.
Ogino, Keiko, Ko Hatanaka, Michiko Kawamura, Makoto Katori, & Yoshiteru Harada. (1997). Evaluation of Pharmacological Profile of Meloxicam as an Anti-Inflammatory Agent, with Particular Reference to Its Relative Selectivity for Cyclooxygenase-2 Over Cyclooxygenase-1. Pharmacology. 55(1). 44–53. 58 indexed citations
11.
12.
Shimizu‐Sasamata, Masao, Sachiko Kawasaki‐Yatsugi, Masamichí Okada, et al.. (1996). YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 84–92. 77 indexed citations
13.
Harada, Yoshiteru, Ko Hatanaka, Michiko Kawamura, et al.. (1996). Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy. Prostaglandins. 51(1). 19–33. 73 indexed citations
14.
Hatanaka, Ko, et al.. (1996). Cell types expressing COX-2 in rat carrageenin-induced pleurisy.. The Japanese Journal of Pharmacology. 71. 304–304. 2 indexed citations
15.
Ogino, Keiko, et al.. (1996). An inhibitory effect of meloxicam, a novel nonsteroidal anti-inflammatory drug, on COX-2.. The Japanese Journal of Pharmacology. 71. 304–304. 1 indexed citations
16.
Hatanaka, Ko, Maki Saito, Masataka Majima, et al.. (1995). Induction of Cyclooxygenase Type-2 (COX-2) in Rat Endometrium at the Peak of Serum Estradiol during the Estrus Cycle. The Japanese Journal of Pharmacology. 69(3). 289–291. 22 indexed citations
17.
Oda, Takuji, Makoto Katori, Ko Hatanaka, & Y. Nagai. (1995). Inhibition of neutrophil migration by a selective inhibitor of matrix metalloproteinase: analysis by intravital microscopy. Mediators of Inflammation. 4(2). 133–137. 6 indexed citations
18.
Katori, Makoto, et al.. (1995). Induction of prostaglandin H synthase-2 in rat carrageenin-induced pleurisy and effect of a selective COX-2 inhibitor.. PubMed. 23. 345–7. 17 indexed citations
19.
Harada, Yoshiteru, Ko Hatanaka, Maki Saito, et al.. (1994). <b>Detection of inducible prostaglandin H synthase-2 in cells in the exudate of rat carrageenin-induced </b><b>pleurisy </b>. Biomedical Research. 15(2). 127–130. 33 indexed citations
20.
Oda, Takuji, Makoto Katori, Ko Hatanaka, & Shohei Yamashina. (1992). Five steps in leukocyte extravasation in the microcirculation by chemoattractants. Mediators of Inflammation. 1(6). 403–409. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Tomlinson Breakdown of academic impact, for papers by Julie Y. Crider Breakdown of academic impact, for papers by Paul DaSilva‐Jardine Breakdown of academic impact, for papers by Seu‐Mei Wang Breakdown of academic impact, for papers by Kenneth E. Eakins Breakdown of academic impact, for papers by Cheng Yun-lin Breakdown of academic impact, for papers by N A Plummer Breakdown of academic impact, for papers by Akira Wakizaka Breakdown of academic impact, for papers by Susumu Otomo Breakdown of academic impact, for papers by Rebecca Salmonsen
Rankless by CCL
2026